Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Rabbit Polyclonal (IgG) to Human PRKCG / PKC-Gamma
IHC, Western blot, ELISA
Human PRKCG / PKC-Gamma
Human, Mammal (tested or 100% immunogen sequence identity)
Western blot (1:250)
Specificity and Use
Synthetic peptide corresponding to a distinct C terminal region, from human protein kinase C gamma.
Based on known homologies, expected to react with the PKC ortholog in most mammalian species.
Suitable for use in Western blots, ELISA, and/or Immunohistochemical techniques. For Immunohistochemistry and Western blotting using alkaline phosphatase or HRP, a dilution of 1:250 is recommended. With a more sensitive detection system, such as enhanced chemiluminescence or ELISA, the antibody may be diluted further. Optimum dilutions to be determined by researcher.
0.05% sodium azide.
Long term: -20°C; Short term: +4°C; Avoid freeze-thaw cycles.
PRKCG Antibody, PKC-gamma Antibody, PRKC-gamma Antibody, Protein kinase C gamma Antibody, Protein kinase C gamma type Antibody, PKC Gamma Antibody, PKCC Antibody, PKCG Antibody, Pkcgamma Antibody, Protein kinase C, gamma Antibody, SCA14 Antibody
Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress.